DI MASI, NICOLA GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 275
AS - Asia 85
EU - Europa 66
SA - Sud America 20
AF - Africa 5
Totale 451
Nazione #
US - Stati Uniti d'America 273
SG - Singapore 39
CN - Cina 16
SE - Svezia 16
BR - Brasile 15
IT - Italia 15
RU - Federazione Russa 11
HK - Hong Kong 9
GB - Regno Unito 8
BE - Belgio 7
VN - Vietnam 6
FR - Francia 5
IN - India 5
TR - Turchia 4
AR - Argentina 3
ZA - Sudafrica 3
BD - Bangladesh 2
MX - Messico 2
PK - Pakistan 2
CO - Colombia 1
CZ - Repubblica Ceca 1
DE - Germania 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
MM - Myanmar 1
PH - Filippine 1
SO - Somalia 1
UA - Ucraina 1
Totale 451
Città #
Chandler 44
Fairfield 34
Ashburn 32
Singapore 24
San Jose 17
Seattle 17
Wilmington 15
Woodbridge 15
Houston 14
Cambridge 13
Nyköping 12
Milan 11
Hong Kong 9
Ann Arbor 7
Brussels 7
Beijing 5
London 4
São Paulo 4
Brooklyn 3
Dearborn 3
Des Moines 3
Falls Church 3
Lawrence 3
Rome 3
Roxbury 3
Stockholm 3
Augusta 2
Dallas 2
Edinburgh 2
Ho Chi Minh City 2
Lauterbourg 2
Moscow 2
Paris 2
Santa Clara 2
The Dalles 2
Ankara 1
Atlanta 1
Aurangabad 1
Baraúna 1
Birmingham 1
Biên Hòa 1
Boardman 1
Bến Tre 1
Carira 1
Charlotte 1
Chennai 1
Comodoro Rivadavia 1
Council Bluffs 1
Davao City 1
Dhaka 1
Embu das Artes 1
Figino 1
Florence 1
Frankfurt am Main 1
Gebze 1
Haiphong 1
Hanoi 1
Hickory 1
Islamabad 1
Istanbul 1
Ituzaingó 1
Kunming 1
Linyi 1
Los Angeles 1
Luzerna 1
Mexico City 1
Monmouth Junction 1
Nanjing 1
New Delhi 1
New York 1
Pasto 1
Paulista 1
Prague 1
Praia Grande 1
Prescot 1
Pretoria 1
Promissão 1
Pune 1
Querétaro 1
Quito 1
Quţūr 1
Río Colorado 1
Springs 1
São Manuel 1
Uberlândia 1
Vitória da Conquista 1
Várzea Paulista 1
Washington 1
Wuxi 1
Yangon 1
Totale 381
Nome #
Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol 163
Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib 157
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 137
Totale 457
Categoria #
all - tutte 1.966
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.966


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202239 1 5 0 3 1 3 3 1 1 3 4 14
2022/202379 7 12 7 7 14 9 2 3 12 0 4 2
2023/202418 1 3 1 4 3 2 0 1 0 0 0 3
2024/202556 1 0 7 1 2 9 7 7 0 5 5 12
2025/2026137 26 4 6 13 17 12 12 2 17 10 4 14
2026/20272 2 0 0 0 0 0 0 0 0 0 0 0
Totale 457